相关实验视频

Updated: Jul 13, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

一个乳化驱动的肺腺癌预后模型:细胞乳化异质性和免疫洞察力

Ziheng Yang¹, Hui Cheng¹, Sheng Zhang¹

¹Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Translational lung cancer research

|January 9, 2026

概括

这项研究揭示了肺腺癌 (LUAD) 的乳化模式,开发了一个12基因预后模型. 高乳化与生存率低下和免疫逃避相关,提供了新的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

乳化是瘤进展和免疫调节中的一个关键的翻译后修改.
细胞异质性和乳化在肺腺癌 (LUAD) 中的功能作用尚不清楚.
这项研究探讨了单细胞水平的乳化,以开发LUAD的预后模型.

研究的目的:

为了在单细胞水平上描述LUAD中的乳化模式.
识别乳化相关基因并开发预后模型.
调查与LUAD中乳糖化相关的免疫相关机制.

主要方法:

对LUAD和正常肺组织的单细胞转录组数据分析.
使用AUCell和332个与乳相关的基因量化乳化活性.
用CellChat和机器学习进行细胞-细胞通信推断,用于预后模型构建.

主要成果:

乳化活性在LUAD上皮细胞和树皮细胞中升高,特别是在特定的亚群中.
确定了12个基因特征 (9个风险,3个保护性),其中ANGPTL4,SOD1和VEGFC是关键风险基因.
预后模型显示出强大的预测性能,高风险患者的生存率较差,免疫特征发生变化.

结论:

开发了一种基于乳的LUAD新型预后模型.
高乳基化上皮细胞可能通过特定的信号通路促进免疫逃避和瘤进展.
这项研究提供了关于LUAD乳酸化免疫相关机制的见解,并提出了潜在的治疗策略.

关键词:

ANGPTL4 在线观看肺腺癌 (LUAD) 是一种肺腺癌.免疫系统是免疫系统的.乳化乳化乳化预测模型的预测模型.

更多相关视频

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...